Hyperosmolar Hyperglycemic State (previously known as “Hyperosmolar Hyperglycemic Nonketotic Syndrome” and, before that, “Hyperosmolar Hyperglycemic Nonketotic Coma”) is a bit of a slippery animal. Despite being redefined several times, the precise definition remains elusive. This may cause it to be over-diagnosed in anyone with severe hyperglycemia. The treatment likewise remains a bit controversial, with different guidelines recommending opposing strategies. Consequently, we may need to rely on a sound understanding of the physiology and some common sense to navigate the confusion of this diagnosis.
-
The IBCC chapter is located here.
- The podcast & comments are below.
Follow us on iTunes![](https://i0.wp.com/emcrit.org/wp-content/uploads/2016/11/apps.40518.14127333176902609.7be7b901-15fe-4c27-863c-7c0dbfc26c5c.5c278f58-912b-4af9-88f8-a65fff2da477.jpg?resize=100%2C100)
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
- PulmCrit Wee: Rational selection of infusion rate based on loading dose - June 25, 2024
- PulmCrit: PPIs are safe and effective for GI prophylaxis… the end. - June 18, 2024
- PulmCrit: Bilevel Sequence Intubation (BSI) – The new standard - June 17, 2024
Nice, thanks for doing this.. however I feel like this chapters missing an “ending.” Can you also talk about “transitioning.” Like DKA you monitor until the gap closes then transition them. What about for HHNK? Are you monitoring serial serum osms? How do you know when you’re done and how do you suggest transitioning. Thanks
hm….
Great, as always.
The UK guidelines talk about using different measures of osmolality/tonicity to monitor and guide response to fluid and insulin therapy. The 3-8mOsm per hour seems pretty aggressive – at the upper end this could be a reduction in osmolality of nearly 200 over 24 hours – and I can’t see how they arrived at this?
The only thing I’d add to your chapter is the importance of VTE prophylaxis (some places still advocating therapeutic doses of LMW heparin?) and watching for pressure sores. Thanks again!
D
By administering insulin, we are decreasing serum osmolality and tonicity and increasing intracellular osmolality and tonicity… leading to tissue swelling?